They recommend carnitine supplementation for patients undergoing hemodialysis who have erythropoietin-resistant anemia, hypotension during hemodialysis sessions, cardiac dysfunction, and muscle weakness [17]. The gene discussed is EPO; the disease is anemia (phenotype).